ANTHONY MOLLOY - 18 Jan 2022 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Chief Lgl & Compliance Officer
Signature
/s/ Kristen Williams, Attorney-in-Fact
Issuer symbol
PCRX
Transactions as of
18 Jan 2022
Net transactions value
-$14,235
Form type
4
Filing time
20 Jan 2022, 18:21:07 UTC
Previous filing
10 Jan 2022
Next filing
08 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Sale $14,235 -224 -1.3% $63.55 17,550 18 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.